Company / Operating Cash Flow per Share
Collegium Pharmaceutical, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$10.39
FY2025
5-year range
$3.08 / $10.39
FY2021-FY2025
Trend
+59.3%
vs FY2024
Sector context
#10 of 212
Health Care
What the data says
Among 212 Health Care companies, Collegium Pharmaceutical, Inc. is in the top 5% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-3.62 in FY2016 to $10.39 in FY2025.
Based on SEC 10-K filings.
10.39 in FY2025 with a 5-year CAGR of +30.8%. Top quartile in the Health Care sector.
Improved from $8.62 to $10.39 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +41.4%
- 5-Year CAGR
- +30.8%
- 10-Year CAGR
- -
Sector benchmark
+170.7% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 59.3% year-over-year.
- Ranks #10 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.39 | +59.3% |
| FY2024 | $6.52 | -24.4% |
| FY2023 | $8.62 | +134.9% |
| FY2022 | $3.67 | +19.3% |
| FY2021 | $3.08 | +13.4% |
| FY2020 | $2.71 | +225.0% |
| FY2019 | $0.84 | -83.8% |
| FY2018 | $5.17 | +803.8% |
| FY2017 | -$0.73 | +79.7% |
| FY2016 | -$3.62 | -127.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026